Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease-Reference-Cited by-同舟云学术

Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease

Published:2020 Issue:4 Volume:38 Page:552
ISSN:2287-4208
Container-title:The World Journal of Men's Health
language:en
Short-container-title:World J Mens Health

Author:

Song Kang-Moon¹^ORCID,Chung Doo Yong¹^ORCID,Choi Min Ji¹^ORCID,Ghatak Kalyan¹^ORCID,Minh Nguyen Nhat¹^ORCID,Limanjaya Anita¹^ORCID,Kwon Mi-Hye¹^ORCID,Ock Jiyeon¹^ORCID,Yin Guo Nan¹^ORCID,Kim Dae-Kee²^ORCID,Ryu Ji-Kan¹^ORCID,Suh Jun-Kyu¹^ORCID

Affiliation:

1. National Research Center for Sexual Medicine and Department of Urology, Inha University School of Medicine, Incheon, Korea.

2. Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewah Womans University, Seoul, Korea.

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

Publisher

Korean Society for Sexual Medicine and Andrology

Subject

Pharmacology (medical),Urology,Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Health Policy,Ageing,Reproductive Medicine

Link

https://wjmh.org/pdf/10.5534/wjmh.190071

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injectable agents for the induction of Peyronie’s disease in model rats: a comparative study;Asian Journal of Andrology;2024-08-13

2. Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines;Advanced Drug Delivery Reviews;2024-06

3. Unveiling the molecular Hallmarks of Peyronie’s disease: a comprehensive narrative review;International Journal of Impotence Research;2024-03-07

4. Transforming growth factor-β receptors: versatile mechanisms of ligand activation;Acta Pharmacologica Sinica;2024-02-13

5. Transcutaneous auricular vagus nerve stimulation in the treatment of disorders of consciousness: mechanisms and applications;Frontiers in Neuroscience;2023-10-18